| Literature DB >> 28187513 |
L D Fiore1, H Rodriguez2, C D Shriver3,4.
Abstract
A tri-federal initiative arising out of the Cancer Moonshot has resulted in the formation of a program to utilize advanced genomic and proteomic expression platforms on high-quality human biospecimens in near-real-time in order to identify potentially actionable therapeutic molecular targets, study the relationship of molecular findings to cancer treatment outcomes, and accelerate novel clinical trials with biomarkers of prognostic and predictive value.Entities:
Mesh:
Year: 2017 PMID: 28187513 DOI: 10.1002/cpt.658
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN: 0009-9236 Impact factor: 6.875